*Corresponding author:
Ashish Baldi, Professor and Head, Department of Pharmaceutical Sciences and Technology, Maharaja Ranjit Singh Punjab Technical University, Bathinda, Punjab, IndiaReceived: September 16, 2017; Published: October 03, 2017
DOI: 10.26717/BJSTR.2017.01.000405
To view the Full Article Peer-reviewed Article PDF
Probiotics, the friendly bugs, has gained impressive attention worldwide due to their nutraceutical and pharmaceutical benefits, established in recent years. However existing regulatory regime in various countries has ambiguities regarding its classification based on intended use and respective approval process. Author and his coworkers have proposed a revised definition and categorization of probiotic products along with possible path to develop a comprehensive guideline for global enactment.
Keywords: Food; Dietary supplements; Health claims; Nutraceuticals; Probiotics; Pharmaceuticals; Regulatory guidelines.
Abstract| Introduction| Current Status of Probiotics| Regulatory Framework for Probiotics: Issues of Concerns| Future Recommendations| Conclusion| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China